BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3390831)

  • 1. Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.
    McCabe RP; Peters LC; Haspel MV; Pomato N; Carrasquillo JA; Hanna MG
    Cancer Res; 1988 Aug; 48(15):4348-53. PubMed ID: 3390831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of human tumor-reactive monoclonal antibody 16.88 in the circulation and localization of 16.88 in colorectal metastatic tumor tissue using murine antiidiotypic antibodies.
    Taddei-Peters WC; Haspel MV; Vente P; Murray JL; Cleary KR; Levin B; Paris EM; Pomato N; Murray JH; Weidman D
    Cancer Res; 1992 May; 52(9):2603-9. PubMed ID: 1568227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
    Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies of mouse monoclonal antibodies to a rat colon carcinoma: I. Comparison of biodistribution in normal rats, syngeneic tumor-bearing rats, or tumor-bearing nude mice.
    Laborda J; Douillard JY; Burg C; Lizzio EF; Ridge J; Levenbook I; Hoffman T
    J Nucl Med; 1990 Jun; 31(6):1028-34. PubMed ID: 2348232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.
    Quadri SM; Malik AB; Tang XZ; Patenia R; Freedman RS; Vriesendorp HM
    Cancer Res; 1995 Dec; 55(23 Suppl):5736s-5742s. PubMed ID: 7493338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
    Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG
    Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of a murine monoclonal antibody to a rat colon tumor in rats and nude mice.
    Laborda J; Douillard JY; Lizzio EF; Hoffman T
    Cancer Res; 1990 Feb; 50(3 Suppl):873s-876s. PubMed ID: 2297736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and man.
    Haisma HJ; Kessel MA; Silva C; van Muijen M; Roos JC; Bril H; Martens HJ; McCabe R; Boven E
    Br J Cancer Suppl; 1990 Jul; 10():40-3. PubMed ID: 2383479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
    Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
    Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.
    Rowlinson-Busza G; Bamias A; Krausz T; Epenetos AA
    Cancer Res; 1991 Jun; 51(12):3251-6. PubMed ID: 2040000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunodetection of implanted tumors with gamma probe.
    Hinkle GH; Abdel-Nabi H; Miller EA; Schlanger LE; Houchens DP; Thurston MO; Aitken DR; Mojzisik CM; Olsen JO; Tuttle SE
    NCI Monogr; 1987; (3):83-7. PubMed ID: 3821922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
    Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.
    Baxter LT; Zhu H; Mackensen DG; Jain RK
    Cancer Res; 1994 Mar; 54(6):1517-28. PubMed ID: 8137258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
    Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.